Adam F. Langhoff
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults.
Journal: NEJM evidence
Published: August 29, 2026
RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial.
Journal: European journal of heart failure
Published: August 08, 2026
Effectiveness of Bivalent RSV Prefusion F Protein-based Vaccine in Individuals With and Without Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial.
Journal: Journal of the American College of Cardiology
Published: August 02, 2026
Effectiveness of High-Dose versus Standard-Dose Influenza Vaccine against Venous Thromboembolic Events: A Post Hoc Analysis of the DANFLU-2 Trial.
Journal: European journal of preventive cardiology
Published: July 31, 2026
Risk of Myocarditis and Pericarditis With Bivalent RSV Prefusion F Protein-Based Vaccine: A Safety Analysis of the Extended DAN-RSV Trial.
Journal: Journal of the American College of Cardiology
Published: July 26, 2026
A Randomized Trial to Investigate the Effects of Low-Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT).
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: March 10, 2026
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: January 12, 2026
Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease.
Journal: NEJM evidence
Published: October 28, 2025
C-Reactive Protein and Long-Term Risk of Death in Patients with Myocardial Infarction.
Journal: Cardiology
Published: September 11, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Journal: The New England journal of medicine
Published: September 01, 2025
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 30, 2025
High-Dose Versus Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial.
Journal: Circulation. Heart failure
Published: August 30, 2025
Last Updated: 09/26/2026